Eversept Partners, LP Glycomimetics Inc Transaction History

Eversept Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 08, 2023	BUY	$1.0 - $1.58 $100,579 - $158,914	100,579 New	100,579 $114,000
Q1 2022 May 16, 2022	BUY	$1.0 - $1.58 $579 - $914	579 Added 0.58%	100,579 $115,000
Q4 2021 Nov 08, 2023	BUY	$1.44 - $2.14 $144,000 - $214,000	100,000 New	100,000 $144,000
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.14 $144,000 - $214,000	100,000 New	100,000 $144,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.